La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
H&R GmbH KGaA Résultats passés
Passé contrôle des critères 2/6
H&R GmbH KGaA has been growing earnings at an average annual rate of 24.2%, while the Chemicals industry saw earnings growing at 17.5% annually. Revenues have been growing at an average rate of 9.1% per year. H&R GmbH KGaA's return on equity is 2.4%, and it has net margins of 0.7%.
Informations clés
24.2%
Taux de croissance des bénéfices
24.2%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 12.4% |
| Taux de croissance des recettes | 9.1% |
| Rendement des fonds propres | 2.4% |
| Marge nette | 0.7% |
| Prochaine mise à jour des résultats | 14 Nov 2024 |
Mises à jour récentes des performances passées
Recent updates
Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Have Stalled
Jul 24
H&R GmbH KGaA (ETR:2HRA) Is Paying Out A Dividend Of €0.10
Apr 26Why H&R GmbH & Co. KGaA (ETR:2HRA) Could Be Worth Watching
Dec 21Is H&R GmbH KGaA (ETR:2HRA) Using Too Much Debt?
Apr 29H&R GmbH KGaA (ETR:2HRA) Has More To Do To Multiply In Value Going Forward
Aug 09These 4 Measures Indicate That H&R GmbH KGaA (ETR:2HRA) Is Using Debt Extensively
Jul 19H&R GmbH KGaA (ETR:2HRA) Has A Somewhat Strained Balance Sheet
Mar 22What Does H&R GmbH & Co. KGaA's (ETR:2HRA) Share Price Indicate?
Feb 22H&R GmbH KGaA (ETR:2HRA) Takes On Some Risk With Its Use Of Debt
Nov 27Is H&R GmbH KGaA (ETR:2HRA) A Risky Investment?
Jul 22The Returns On Capital At H&R GmbH KGaA (ETR:2HRA) Don't Inspire Confidence
May 26H&R GmbH & Co. KGaA (ETR:2HRA) Shares Could Be 40% Below Their Intrinsic Value Estimate
Apr 29H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?
Mar 28H&R GmbH KGaA's (ETR:2HRA) Shareholders Are Down 57% On Their Shares
Feb 04
H&R GmbH KGaA (ETR:2HRA) Has Debt But No Earnings; Should You Worry?
Dec 13Ventilation des recettes et des dépenses
Comment H&R GmbH KGaA gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 1,340 | 10 | 107 | 0 |
| 31 Mar 24 | 1,350 | 13 | 106 | 0 |
| 31 Dec 23 | 1,363 | 11 | 106 | 0 |
| 30 Sep 23 | 1,412 | 14 | 106 | 0 |
| 30 Jun 23 | 1,493 | 17 | 108 | 0 |
| 31 Mar 23 | 1,579 | 34 | 105 | 0 |
| 31 Dec 22 | 1,585 | 43 | 102 | 0 |
| 30 Sep 22 | 1,540 | 43 | 107 | 0 |
| 30 Jun 22 | 1,441 | 49 | 104 | 0 |
| 31 Mar 22 | 1,314 | 51 | 103 | 0 |
| 31 Dec 21 | 1,193 | 50 | 101 | 0 |
| 30 Sep 21 | 1,107 | 53 | 94 | 0 |
| 30 Jun 21 | 995 | 36 | 89 | 0 |
| 31 Mar 21 | 860 | 3 | 86 | 0 |
| 31 Dec 20 | 879 | -9 | 85 | 0 |
| 30 Sep 20 | 906 | -20 | 87 | 0 |
| 30 Jun 20 | 973 | -25 | 88 | 0 |
| 31 Mar 20 | 1,054 | -11 | 90 | 0 |
| 31 Dec 19 | 1,081 | -1 | 91 | 0 |
| 30 Sep 19 | 1,112 | 5 | 101 | 0 |
| 30 Jun 19 | 1,120 | 17 | 100 | 0 |
| 31 Mar 19 | 1,136 | 17 | 100 | 0 |
| 31 Dec 18 | 1,121 | 22 | 99 | 0 |
| 30 Sep 18 | 1,080 | 18 | 99 | 0 |
| 30 Jun 18 | 1,054 | 26 | 99 | 0 |
| 31 Mar 18 | 1,035 | 32 | 99 | 0 |
| 31 Dec 17 | 1,031 | 32 | 98 | 0 |
| 30 Sep 17 | 1,028 | 35 | 99 | 0 |
| 30 Jun 17 | 1,011 | 33 | 98 | 0 |
| 31 Mar 17 | 988 | 35 | 98 | 0 |
| 31 Dec 16 | 948 | 38 | 99 | 0 |
| 30 Sep 16 | 928 | 35 | 97 | 0 |
| 30 Jun 16 | 928 | 35 | 97 | 0 |
| 31 Mar 16 | 953 | 36 | 96 | 0 |
| 31 Dec 15 | 988 | 27 | 93 | 0 |
| 30 Sep 15 | 1,023 | 16 | 92 | 0 |
| 30 Jun 15 | 1,048 | 5 | 90 | 0 |
| 31 Mar 15 | 1,044 | -10 | 87 | 0 |
| 31 Dec 14 | 1,064 | -15 | 85 | 0 |
| 30 Sep 14 | 1,085 | -4 | 82 | 0 |
| 30 Jun 14 | 1,173 | -13 | 83 | 0 |
| 31 Mar 14 | 1,201 | -12 | 83 | 0 |
| 31 Dec 13 | 1,220 | -14 | 84 | 0 |
| 30 Sep 13 | 1,227 | -22 | 87 | 0 |
Des revenus de qualité: 2HRA has high quality earnings.
Augmentation de la marge bénéficiaire: 2HRA's current net profit margins (0.7%) are lower than last year (1.1%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 2HRA's earnings have grown significantly by 24.2% per year over the past 5 years.
Accélération de la croissance: 2HRA's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: 2HRA had negative earnings growth (-42.7%) over the past year, making it difficult to compare to the Chemicals industry average (5%).
Rendement des fonds propres
ROE élevé: 2HRA's Return on Equity (2.4%) is considered low.